Skip to main content
. 2020 Aug 25;11(34):3227–3243. doi: 10.18632/oncotarget.27693

Table 2.

Aggregate analysis of (OT-10, OT-11, OT-18, OT-19, OT-23 and OT-24) and control (OC-2, OC-6, OC-22) samples along with other OSCC and control samples processed on Oncoscan array, we identified significant copy number gain and copy number loss showing CNV overlap and frequency

Region Region Length Cytoband Location Event Genes miRNAs Frequency % p-value % of CNV Overlap Count of Gene Symbols Cancer Gene Census-Sanger.txt
chr2:89,138,631-89,389,171 250540 p11.2 CN Gain 0 0 36.36364 0.002 100 0
chr3:52,631,633-52,741,160 109527 p21.1 CN Loss 9 0 54.54545 0.048 0.318643 9 PBRM1
chr3:60,380,259-60,571,437 191178 p14.2 CN Loss 1 0 54.54545 0.048 25.46527 1 FHIT
chr7:55,114,950-55,124,319 9369 p11.2 CN Gain 1 0 81.81818 0.004 100 1 EGFR
chr9:21,903,166-22,027,402 124236 p21.3 CN Loss 4 0 36.36364 0.002 100 4
chr9:22,028,315-22,140,224 111909 p21.3 CN Loss 1 0 36.36364 0.002 100 1
chr11:69,508,372-70,096,585 588213 q13.3 CN Gain 7 0 72.72727 0.002 7.257745 7
chr11:70,120,785-70,158,876 38091 q13.3 CN Gain 2 1 72.72727 0.002 11.77969 2
chr11:70,172,204-70,289,645 117441 q13.3 CN Gain 2 0 72.72727 0.002 39.32443 2
chr11:70,295,897-70,420,282 124385 q13.3–q13.4 CN Gain 1 0 72.72727 0.002 0 1
chr12:132,982,204-133,331,537 349333 q24.33 CN Loss 8 0 36.36364 0.001 32.73724 8
chr16:1,154,125-1,486,352 332227 p13.3 CN Loss 12 0 45.45455 0.01 100 12
chr16:1,790,665-2,305,328 514663 p13.3 CN Loss 50 1 45.45455 0.01 79.73334 50 TSC2
chr16:88,846,849-88,874,778 27929 q24.3 CN Loss 2 0 36.36364 0 30.77804 2
chr19:1,225,825-1,259,625 33800 p13.3 CN Loss 4 0 45.45455 0.038 100 4 STK11
chr21:46,869,264-47,061,267 192003 q22.3 CN Loss 4 0 63.63636 0.003 91.45586 4
chr21:47,155,316-47,841,692 686376 q22.3 CN Loss 15 0 63.63636 0.003 13.00585 15
chr22:22,266,808-22,289,397 22589 q11.22 CN Gain 1 0 36.36364 0.013 100 1
chrX:177,942-2,686,899 2508957 p22.33 CN Gain 24 0 63.63636 0 29.06012 24 CRLF2, P2RY8
chrX:154,479,421-154,929,412 449991 q28 CN Gain 26 2 45.45455 0.008 100 26
chrX:154,979,673-155,219,364 239691 q28 CN Gain 2 0 63.63636 0 97.69119 2